Literature DB >> 9426470

The benzodiazepine binding site of GABAA receptors.

E Sigel1, A Buhr.   

Abstract

The GABAA receptor belongs, along with the nicotinic acetylcholine receptor, the glycine receptor and the 5-HT3 receptor, to a family of homologous transmitter-gated ion channels mediating fast synaptic transmission. Many classes of drug interact with the GABAA receptor, which is the major inhibitory ion channel in the mammalian brain. Among these drugs are the allosteric modulators acting at the benzodiazepine binding site. In this article, Erwin Sigel and Andreas Buhr discuss recent studies that have identified amino acid residues that are thought to form the binding pocket for these compounds. These residues are probably located at subunit interfaces of the protein pentamer and at least some of them are homologous to residues implicated in channel agonist binding. This implies pseudosymmetry of channel agonist and channel modulatory sites, which may be, as recent data indicate, a general principle realized in other pseudosymmetric protein complexes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9426470     DOI: 10.1016/s0165-6147(97)01118-8

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  120 in total

1.  Two gamma2L subunit domains confer low Zn2+ sensitivity to ternary GABA(A) receptors.

Authors:  N Nagaya; R L Macdonald
Journal:  J Physiol       Date:  2001-04-01       Impact factor: 5.182

Review 2.  General anaesthetic actions on ligand-gated ion channels.

Authors:  M D Krasowski; N L Harrison
Journal:  Cell Mol Life Sci       Date:  1999-08-15       Impact factor: 9.261

3.  Dual mode of stimulation by the beta-carboline ZK 91085 of recombinant GABA(A) receptor currents: molecular determinants affecting its action.

Authors:  U Thomet; R Baur; P Scholze; W Sieghart; E Sigel
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

4.  Allosteric modulators affect the efficacy of partial agonists for recombinant GABA(A) receptors.

Authors:  G Maksay; S A Thompson; K A Wafford
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 5.  Neurochemical and molecular pharmacological aspects of the GABA(B) receptor.

Authors:  K Kuriyama; M Hirouchi; H Kimura
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

6.  Agonist Trapping by GABAA Receptor Channels.

Authors:  M T Bianchi; R L Macdonald
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

7.  Anxiolytic drug targets: beyond the usual suspects.

Authors:  Joshua A Gordon
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 8.  Neuroimaging insights into the role of cortical GABA systems and the influence of nicotine on the recovery from alcohol dependence.

Authors:  Kelly P Cosgrove; Irina Esterlis; Graeme F Mason; Frederic Bois; Stephanie S O'Malley; John H Krystal
Journal:  Neuropharmacology       Date:  2011-01-27       Impact factor: 5.250

9.  Potentiation of a neuronal nicotinic receptor via pseudo-agonist site.

Authors:  Simone Mazzaferro; Isabel Bermudez; Steven M Sine
Journal:  Cell Mol Life Sci       Date:  2019-01-01       Impact factor: 9.261

10.  Expression of functional neurotransmitter receptors in Xenopus oocytes after injection of human brain membranes.

Authors:  Ricardo Miledi; Fabrizio Eusebi; Ataúlfo Martínez-Torres; Eleonora Palma; Flavia Trettel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.